The discreet wearable device administers their proprietary neuromuscular electrical stimulation to neutralise the two main causes of menstrual pain, uterine cramps and inflammation, providing drug-free, long-lasting relief.

electronRx CEO and Founder, Dr. Bipin Patel, shares his excitement: “Ohmm is an opportunity to make a difference to the lives of billions of women around the world needlessly enduring pain in silence.”

According to the WHO, dysmenorrhea may affect up to 81% of women of reproductive age. This grant will allow the eRx team to develop on the current prototype and run the clinical studies that will take the device through regulatory approval.

Ohmm hopes to provide a serious solution to treating dysmenorrhea; a condition which has until now been incredibly underserved by the medical field.

The Ohmm technology will not only revolutionise pain management for dysmenorrhea, but potentially has wider ramifications for the treatment of chronic pain in general, from lower back pain to migraines and cluster headaches, negating the need for opioid use and the potential issues associated with this.

Keep your eyes peeled for our interview with electronRx coming soon!